瓦克赛特生物

US · PCVX #1630 按市值排名上市于 2020

63.62 -1.65 -2.53%

实时 - 追踪5344个代码 - 心跳于315秒前 · 2026-10-16 19:30

✦ 量化股权信号计算方式说明

减持

最近一期（2026/Q3）披露持股的机构数量减少了6家。
机构持股总比例下降了3.4个百分点。

机构持股

机构持股比例: 113.30% -3.35pp
机构数量: 400 -6
数据截至: 2026/Q3 较上一报告期

持股变动 vs 资金流向

方向一致

机构在上一报告期减持了股份，同时该股在最近20个交易日的主力资金呈净流出——两者方向一致。

机构持股变动数据按季度发布且存在滞后；资金流向数据为每日更新。请将其作为方向性的交叉验证参考，而非精确的择时信号。

持股人类型

Mutual Fund84.47%

Hedge Fund12.65%

VC/PE Fund12.22%

Public Company1.81%

Sovereign Wealth Fund0.84%

Individual/Insider0.60%

Government Pension Fund0.56%

Private Company0.52%

Insurance Company0.20%

主要股东截至 2026-06-30

FMR 12.87% · 19.15M 股

Janus Henderson Group plc 12.12% · 18.04M 股

T. Rowe Price Group, Inc. 10.21% · 15.20M 股

BlackRock 8.11% · 12.07M 股

RA Capital Management, L.P. 7.71% · 11.47M 股

Vanguard Capital Management, LLC 4.89% · 7.28M 股

Wellington Management Group 4.71% · 7.00M 股

Vanguard Portfolio Management, LLC 4.43% · 6.59M 股

State Street Global Advisors 3.60% · 5.35M 股

Deep Track Capital, LP 2.89% · 4.30M 股

条形长度是相对于此处列出的最大股东而言，并非相对于公司100%股权。

内部人持股

共追踪50份申报 · 19次买入 · 30次卖出

姓名	职务	持股比例
Grant Pickering	Chief Executive Officer	0.39%
Andrew Guggenhime	President	0.07%
James Wassil	Chief Operating Officer	0.07%
Harpreet Dhaliwal	--	0.01%
Heath Lukatch	Independent Director	0.01%
Elvia Cowan	Senior VP of Finance & Principal Accounting Officer	0.01%
Halley Gilbert	Independent Director	0.01%
Teri Loxam	Independent Director	0.01%
Annie Drapeau	Independent Director	0.01%
Carlos Paya	Independent Chairperson	0.01%

内部人交易最近的 Form 4 申报记录

日期	姓名	职务	类型	股数	价格
2026-10-04	James Wassil	Chief Operating Officer	Intent to Sell (Form 144)	-18,000	$86.74
2026-10-04	Elvia Cowan	Senior VP of Finance & Principal Accounting Officer	Intent to Sell (Form 144)	-19,000	$86.74
2026-09-30	James Wassil	Chief Operating Officer	Derivative Exercise and Sale	-2,250	$5.35–57.09
2026-09-08	James Wassil	Chief Operating Officer	Automatic Disposition	-2,715	$59.52–61.16
2026-09-08	James Wassil	Chief Operating Officer	Intent to Sell (Form 144)	-1,334	$59.99
2026-09-07	Andrew Guggenhime	President	Sale to Issuer	-7,155	$60.36
2026-09-07	Grant Pickering	Chief Executive Officer	Sale to Issuer	-17,056	$60.36
2026-09-07	James Wassil	Chief Operating Officer	Sale to Issuer	-5,459	$60.36
2026-09-07	Elvia Cowan	Senior VP of Finance & Principal Accounting Officer	Sale to Issuer	-1,327	$60.36
2026-09-07	Harpreet Dhaliwal	--	Sale to Issuer	-7,651	$60.36
2026-09-03	James Wassil	Chief Operating Officer	Intent to Sell (Form 144)	-1,381	$59.73
2026-09-03	Luis Jodar	Chief Medical Officer	Other Acquisition	+52,632	--
2026-09-03	Luis Jodar	Chief Medical Officer	Other Derivative Acquisition	+88,254	$61.16
2026-09-01	Andrew Guggenhime	President	Sale to Issuer	-2,705	$60.74–61.58
2026-09-01	Grant Pickering	Chief Executive Officer	Sale to Issuer	-6,289	$60.74–61.58
2026-09-01	James Wassil	Chief Operating Officer	Sale to Issuer	-2,705	$60.74–61.58
2026-09-01	Elvia Cowan	Senior VP of Finance & Principal Accounting Officer	Sale to Issuer	-569	$60.74–61.58
2026-09-01	Harpreet Dhaliwal	--	Sale to Issuer	-1,020	$60.74–61.58
2026-08-31	James Wassil	Chief Operating Officer	Automatic Disposition	-1,227	$60.96–61.42
2026-08-31	James Wassil	Chief Operating Officer	Derivative Exercise and Sale	-2,250	$5.35–61.48

Form 4 申报记录，每家公司显示最新的一批。"Other Derivative Acquisition"（其他衍生品获取）类目多为限制性股票/期权归属，并非公开市场买入——具体类型见"类型"列。

报价时间 2026-10-16 19:30:04 · 仅供参考，不构成投资建议，也未考虑您的具体情况。